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AbstrACt
Objectives To explore prevalences and occupational 
group inequalities of two measures of multimorbidity with 
frailty.
Design Cross- sectional study.
setting The Nord- Trøndelag Health Study (HUNT), Norway, 
a total county population health survey, 2006–2008.
Participants Participants older than 25 years, with 
complete questionnaires, measurements and occupation 
data were included.
Outcomes ≥2 of 51 multimorbid conditions with 
≥1 of 4 frailty measures (poor health, mental illness, 
physical impairment or social impairment) and ≥3 of 51 
multimorbid conditions with ≥2 of 4 frailty measures.
Analysis Logistic regression models with age and 
occupational group were specified for each sex separately.
results Of 41 193 adults, 38 027 (55% female; 
25–100 years old) were included. Of them, 39% had ≥2 
multimorbid conditions with ≥1 frailty measure, and 17% 
had ≥3 multimorbid conditions with ≥2 frailty measures. 
Prevalence differences in percentage points (pp) with 
95% confidence intervals of those in high versus low 
occupational group with ≥2 multimorbid conditions and ≥1 
frailty measure were largest in women age 30 years, 17 
(14 to 20) pp and 55 years, 15 (13 to 17) pp and in men 
age 55 years, 15 (13 to 17) pp and 80 years, 14 (9 to 18) 
pp. In those with ≥3 multimorbid conditions and ≥2 frailty 
measures, prevalence differences were largest in women 
age 30 years, 8 (6 to 10) pp and 55 years, 10 (8 to 11) 
ppand in men age 55 years, 9 (8 to 11) pp and 80 years, 6 
(95% CI 1 to 10) pp.
Conclusion Multimorbidity with frailty is common, and 
social inequalities persist until age 80 years in women 
and throughout the lifespan in men. To manage complex 
multimorbidity, strategies for proportionate universalism 
in medical education, healthcare, public health prevention 
and promotion seem necessary.
IntrODuCtIOn
Multimorbidity, the co- occurrence of 
multiple, chronic conditions, where none is 
more central,1 is increasingly prevalent and 
is becoming the norm.2–4 Multimorbidity is 
associated with high healthcare utilisation5 
and challenges clinicians in a fragmented 
healthcare system, aided by single disease 
guidelines.6 The treatment burden to patients 
is often substantial including lowered ability 
to self- care.6 Ways to harmonise guidelines 
to fit multimorbidity7 8 and manage patients 
with multimorbidity in clinical practice6 have 
been explored, and specific multimorbidity 
care guidelines are emerging.9 10
Multimorbidity alone may not imply a 
need for complex, multidisciplinary care.1 
Sociodemographic characteristics, individual 
health and social experiences, and mental 
and somatic health characteristics11 increase 
patient complexity. The British National 
Institute for Health and Care Excellence 
(NICE) guideline10 defines multimorbidity 
as two or more long- term, single- count 
health conditions and recommends a multi-
morbid approach to care in various contexts, 
strengths and limitations of this study
 ► The HUNT Study is a large total county population 
general health survey with a multitude of variables, 
suitable to estimate prevalences of multimorbidity 
and frailty by self- reports and clinical measurements.
 ► Occupation is used as a marker for socioeconomic 
position, enabling international comparison.
 ► Sex- specific occupational group differences in mul-
timorbidity with frailty are reported as both absolute 
and relative measures of inequality.
 ► As a secondary analysis, the measures in this study 
need to be adjusted to fit previously collected data.
 ► In particular, the original data lacked information of 
chronicity of conditions, which may lead to overesti-
mation of multimorbidity.
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Figure 1 Flowchart for sample selection: inclusion and 
exclusion criteria and missing data.
including mixed mental and somatic multimorbidity and 
multimorbidity with frailty.
Frailty increases the vulnerability for adverse outcomes. 
It has been understood as characterised by loss of biophys-
ical reserves in elderly,12 operationalised as the frailty 
phenotype.12 Another approach is the frailty index,13 
which calculates a ratio of accumulation of numerous 
deficits in several domains. An opinion of experts further 
emphasises the latter multidimensional view and defines 
frailty as a dynamic state of multicausality, involving loss 
of function in spheres such as physical, psychological 
and social domains.14 This can be regarded as a biopsy-
chosocial frailty model.15 The NICE guideline proposes 
identification of frailty through observation of a low gait 
speed or poor self- rated health or by scoring a frailty scale 
combining demographic characteristics and multidimen-
sional impairments.10
Social health inequalities are established; low socio-
economic position is associated with poorer health 
outcomes in Nordic countries16 and globally.17 Multi-
morbidity and frailty are no exception. Common deter-
minants are socioeconomic deprivation,18 19 female 
sex18 20 and higher age.18 20 In descriptive studies, any 
indicator of socioeconomic position will detect occurring 
differences.21 Socioeconomic gradients in prevalence of 
multimorbidity and frailty have been explored by educa-
tion,18 19 22 23 income,22 23 occupation3 and deprivation 
indexes.18 19 Occupation is associated with education and 
income and may have an impact on health outcomes 
through biopsychosocial work exposures.21 Although 
proportions with multimorbidity and frailty increase with 
higher age, more multimorbid are young and middle 
aged than old,4 24 and frailty is associated with multimor-
bidity and mortality from middle age.25 The NICE guide-
line emphasises assessment of a multimorbid approach to 
care for adults of all ages but does not take into account 
social position.
There are numerous operational definitions of both 
multimorbidity and frailty and prevalence vary by setting, 
definitions and methods.18 26–28 The literature suggests 
that multimorbidity, defined as three or more single 
health conditions, increases specificity especially in older 
age groups.26 29 Common frailty scales require multidi-
mensional loss of function to identify frail individuals20 
and share ability to show associations to age, sex and 
mortality.20
The overall purpose of this study is to identify how many 
in a general adult population is likely to need complex, 
multidisciplinary care as given by one of the contexts 
suggested by the NICE guideline; multimorbidity with 
frailty. Two measures will be assessed, one in line with 
the guideline (two conditions of multimorbidity plus 
one dimension of frailty) and the other with expected 
increased specificity (three conditions of multimorbidity 
plus two dimensions of frailty). The second aim is to 
examine associations of these measures according to age, 
sex and socioeconomic position.
MAterIAls AnD MethODs
reporting statement
The STROBE (Strengthening the Reporting of Observa-
tional Studies in Epidemiology) cross- sectional reporting 
guidelines30 were used for reporting this observational 
study.
study design and population
This cross- sectional study use data from the third wave 
in the Norwegian HUNT Study (the HUNT3 Survey, 
2006–2008). Details on data collection and the cohort 
profile of this total county population health survey were 
published previously.31 In brief, 93 860 residents older 
than 20 years were invited. Of these. 54% (n=50 807 of 
93 860) completed the main questionnaire, meeting the 
minimum requirement for HUNT3 Survey attendance.31 
Figure 1 presents the sample selection for this analysis.
Eighty- one per cent (41 193 of 50 807) of eligible partic-
ipants completed all major parts of the HUNT3 Survey; 
the main, age- specific and sex- specific questionnaires, 
interviews and measurements. Incomplete participation 
excluded 9610 individuals, while four missed complete 
information on participation. Of the responders, 1569 
were younger than 25 years and were excluded on the 
assumption that the highest level of occupational group 
may not yet be obtained by those in this age category. 
One missed information on age. A total of 1571 individ-
uals missed information on occupation, while 25 people 
had ‘unspecified occupation’ and was excluded. Of 41 
193 (92%) participants, 38 027 were included in the final 
sample.
Overall, lower socioeconomic position was associated 
with lower participation rate in the HUNT3 Survey.32 In 
this study, the distribution of occupational groups was 
24% (high), 27% (middle) and 49% (low) in the sample 
and 17% (high), 20% (middle), 52% (low) and 11% 
(missing) among non- eligible. One hundred per cent 
of the missing were due to missing classifiable occupa-
tional data. Women constituted 55%, 51% and 81% of 
the sample, non- eligible and missing, respectively. The 
mean (SD) age was 55 (14) years in the sample, 44 (18) 
years among non- eligible and 66 (18) years among those 
missing data.
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box 1 Continued
XVIII symptoms/signs/abnormal clinical/laboratory findings
Nocturia. Chronic widespread pain.
*Exception to single entity.
COPD, Chronic Obstructive Pulmonary Disease.
box 1 Conditions grouped by ICD-10 chapter
ICD-10 chapter
Conditions
II neoplasms
Cancer
III blood/blood- forming organs/immune mechanism
Sarcoidosis
IV endocrine/nutritional/metabolic
Obesity
Hypercholesterolemia
Diabetes
Hypothyroidism
Hyperthyroidism
V Mental/behavioural
Alcohol problem
Depression
Anxiety
Insomnia
Nervous system
Epilepsy
Migraine
Chronic headache, other
VII eye/adnexa
Cataract
Macula degeneration
Glaucoma
VIII ear/mastoid
Hearing impairment
IX Circulatory system
Hypertension
Angina pectoris
Myocardial infarction
Heart failure
Other heart disease*
Stroke or brain haemorrhage*
X respiratory system
Chronic bronchitis, emphysema or COPD*
Asthma
XI Digestive system
Dental health status
Gastro- oesophageal reflux disease
Irritable bowel syndrome
XII skin/subcutaneous tissue
Hand eczema
Psoriasis
XIII Musculoskeletal/connective tissue
Rheumatoid arthritis
Osteoarthritis
Ankylosing spondylitis
Fibromyalgia
Osteoporosis
Local musculoskeletal pain/stiffness in:
Neck or upper back or lower back or shoulder or elbow or
Hand or hip or knee or foot/ankle
XIV Genitourinary system
Kidney disease
Urine incontinence
Prostate symptoms
Menopausal hot flashes
Continued
Demographic and socioeconomic characteristics
Sex and age at participation in the HUNT3 Survey was 
constructed by the HUNT Databank. Occupational group 
was used as indicator of socioeconomic position.21 In the 
HUNT3 Survey interview, all participants were asked, 
“What is/was the title of your main occupation?” Free- 
text answers were manually categorised corresponding 
to Standard Classifications of Occupations by Statistics 
Norway,33 which is based on the International Standard 
Classification of Occupations–88.34 Occupational socio-
economic position was operationalised using occupa-
tion only, corresponding to a simplified version of the 
European Socio- economic Classification scheme.35 The 
scheme aims to differentiate occupational groups on 
employment relationships and is not hierarchical per se. 
Still, the higher occupational groups are likely to have 
higher and more secure income.35 Collapsed to a three- 
class version, the high level represents large employers, 
higher grade and lower grade professionals, administra-
tive and managerial occupations, and higher grade tech-
nician and supervisory occupations. The middle group 
consists of small employers, self- employed individuals, 
and lower- grade supervisory and technician occupations. 
The low level contains lower- grade service positions, 
sales and clerical occupations, and lower- grade technical 
and routine occupations. Details are provided in online 
supplementary appendix A.
Outcomes
Multimorbidity
The construction of 51 single, chronic conditions from 
the HUNT3 Survey data is described in online supple-
mentary appendix B. Box 1 lists the 51 conditions by 
14 International Classification of Diseases 10th Revision 
(ICD-10) chapters, a disease classification system in major 
organised by organ systems. In this study, a simple, non- 
weighted summary score was generated and two multi-
morbidity variables created, with cut- off values of at least 
2 of 51 and 3 of 51 conditions.
Frailty
Original data did not match any exact frailty scale. A qual-
itative judgement of available data was undertaken and 
general, mental, physical and social dimensions10 14 20 of 
frailty were operationalised from six original variables:
1. General health status, defined as those reporting the 
answers ‘poor’ or ‘not so good’ (vs ‘good’ and ‘very 
good’) to the single question, “How is your health at 
the moment?”
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Table 1 Sex and age distribution by occupational group
Occupational group
High Middle Low Total
Frequency (%) Frequency (%) Frequency (%) Frequency (%)
Total 8 970 (100) 10 243 (100) 18 814 (100) 38 027 (100)
Sex
Female 4 505 (50) 5 386 (53) 10 922 (58) 20 813 (55)
Male 4 465 (50) 4 857 (47) 7 892 (42) 17 214 (45)
Age, years
25–44 2 837 (32) 2 600 (25) 4 487 (24) 9 924 (26)
45–64 4 468 (50) 4 787 (47) 8 951 (48) 18 206 (48)
65–74 1 118 (12) 1 846 (18) 3 297 (18) 6 261 (16)
75–100 547 (6) 1 010 (10) 2 079 (11) 3 636 (10)
2. Mental health status, included those reporting symp-
toms of anxiety and/or depression, on the Hospital 
Anxiety and Depression Scale. The HUNT Databank 
calculated a total score for subscales of anxiety and 
depression, if all items for anxiety and depression, re-
spectively, were answered. In this study, cut- off was set 
at 8/21 points for both conditions36 and a combined 
variable was created.
3. Physical impairment was identified by combining those 
reporting ‘yes’ (vs ‘no’) in response to the question, 
“Do you suffer from any long- term (at least 1 year) 
illness or injury of a physical or psychological nature 
that impairs your functioning in your daily life?” and 
reporting either motor ability, vision or hearing im-
pairment to a moderate or severe degree.
4. Social impairment was derived from answers to the sin-
gle question, “To what extent has your physical health 
or emotional problems limited you in your usual so-
cializing with family or friends during the last 4 weeks?” 
Included were those reporting ‘much’ and ‘not able to 
socialise’ (vs ‘not at all,’ ‘very little,’ or ‘somewhat’).
A summary score was generated and two frailty varia-
bles created, with cut- off values of at least one of four and 
two of four frailty measures with impairment.
Multimorbidity with frailty
The two final outcome variables were created by 
combining self- reported multimorbidity and frailty as at 
least 2 of 51 chronic health conditions plus impairment 
in 1 of 4 dimensions of frailty and 3 of 51 chronic health 
conditions plus impairments in 2 of 4 dimensions of 
frailty.
statistical analysis
We used cross- tables to identify sociodemographic char-
acteristics by occupational group (table 1) and by multi-
morbidity with frailty, stratified by sex (table 2).
Associations between occupational group and the two 
measures of multimorbidity with frailty were analysed 
using logistic regression, adjusted for age and sex. All 
models were stratified by sex and included occupational 
group, continuous age, age squared and an interaction 
term between occupational group and age. Likelihood 
ratio tests were used to compare models.
Given the high prevalence of multimorbidity with frailty 
and the knowledge that odds ratios will deviate from rela-
tive risks,37 we used postestimation commands to obtain 
prevalence differences and prevalence ratios38 between 
the occupational groups with high occupational group as 
the reference category. The prevalence difference is the 
difference in mean predicted probability, and prevalence 
ratio is the ratio between the mean predicted probabili-
ties while holding other covariates constant.38 Prevalence 
difference and prevalence ratio between occupational 
groups were calculated at age 25–100 years in 5- year inter-
vals (online supplementary appendix C). Calculations 
(with 95% confidence intervals) are presented at the ages 
30, 55 and 80 years to reflect young adults, middle aged 
and elderly (table 3).
We performed complete case analysis and used Stata 
V.15.1 (StataCorp., College Station, Texas, USA) to 
analyse the data.
Patient and public involvement
During the preparation of the HUNT3 Survey, there was 
a wide citizen and stakeholder participation. This study 
is a secondary analysis of data collected in 2006–2008. 
Multimorbidity is a universal topic, not represented by 
any particular patient group, thus no patient or public 
representatives were involved in designing the study.
results
A total of 38 027 individuals, older than 25 years, who had 
completed all major parts of the HUNT3 Survey and had 
data on occupation, comprised the final sample for this 
study (figure 1). Further sociodemographic characteris-
tics are presented in table 1.
Most participants, 49% (n=18 814 of 38 027), are cate-
gorised as low occupational group, which is comprised of 
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Table 2 Frequency distribution of two definitions of multimorbidity with frailty across occupational groups and age categories, 
stratified by sex
Women Men
Two conditions of multimorbidityand one dimension of 
frailty*
Two conditions of multimorbidity and one dimension of 
frailty*
No, freq. (%) Yes, freq. (%)
Total, 
freq. (%) No, freq. (%) Yes, freq. (%)
Total, 
freq. (%)
Total 12 304 (59) 8 482 (41) 20 813 (100) 10 826 (63) 6 378 (37) 17 214 (100)
Occupational group
High 3 222 (72) 1 282 (28) 4 505 (100) 3 220 (72) 1 242 (28) 4 465 (100)
Middle 3 370 (63) 2 009 (37) 5 386 (100) 2 995 (62) 1 860 (38) 4 857 (100)
Low 5 712 (52) 5191 (48) 10 922 (100) 4 611 (58) 3 276 (42) 7 892 (100)
Age, years
25–44 4 298 (72) 1 680 (28) 5 981 (100) 3 075 (78) 867 (22) 3 943 (100)
45–64 5 712 (58) 4 122 (42) 9 840 (100) 5 398 (65) 2 967 (35) 8 366 (100)
65–74 1 615 (51) 1 548 (49) 3 168 (100) 1 681 (54) 1 409 (46) 3 093 (100)
75–100 679 (37) 1 132 (62) 1 824 (100) 672 (37) 1 135 (63) 1 812 (100)
Mean (SD) 52 (14) 58 (14) 54 (14) 54 (14) 61 (14) 56 (14)
Three conditions of multimorbidity and two dimensions 
of frailty*
Three conditions of multimorbidity and two dimensions 
of frailty*
No, freq. (%) Yes, freq. (%) Total, 
freq.
(%) No, freq. (%) Yes, freq. (%) Total, 
freq.
(%)
Total 16 983 (82) 3 803 (18) 20 813 (100) 14 367 (83) 2 837 (16) 17 214 (100)
Occupational group
High 4 029 (89) 475 (11) 4 505 (100) 3 977 (89) 485 (11) 4 465 (100)
Middle 4 491 (83) 888 (16) 5 386 (100) 3 995 (82) 860 (18) 4 857 (100)
Low 8 463 (77) 2 440 (22) 10 922 (100) 6 395 (81) 1 492 (19) 7 892 (100)
Age, years
25–44 5378 (90) 600 (10) 5 981 (100) 3 651 (93) 291 (7) 3 943 (100)
45–64 7920 (80) 1914 (19) 9 840 (100) 7 024 (84) 1 341 (16) 8 366 (100)
65–74 2449 (77) 714 (23) 3 168 (100) 2 472 (80) 618 (20) 3 093 (100)
75–100 1236 (68) 575 (32) 1 824 (100) 1 220 (67) 587 (32) 1 812 (100)
Mean (SD) 53 (14) 60 (14) 54 (14) 55 (14) 63 (13) 56 (14)
*In total, 27 women and 10 men miss data on both measures of multimorbidity with frailty.
freq., frequency.
58% (n=10 922 of 18 814) women, while women consti-
tute 55% (n=20 813 of 38 027) of the total sample.
In total, 77% reported more than two and 62% more 
than three conditions of multimorbidity. Frailty with one 
impairment was identified in 41% and with two impair-
ments in 18%. Table 2 shows the distribution of the 
combined measures across occupational groups and strat-
ified by sex.
Overall, 39% met the criteria of having at least two 
conditions of multimorbidity with one dimension of 
frailty (41% (n=8 482 of 20 813) of women, 37% (n=6 378 
of 17 214) of men) and 17% met the criteria of three- 
condition multimorbidity with two dimensions of frailty 
(18% (n=3 803 of 20 813) of women, 16% (n=2 837 of 17 
214) of men).
Proportions of multimorbidity with frailty increased 
with lower occupational rank and increasing age, in both 
sexes, regardless of definition. Most individuals with any 
definition of multimorbidity with frailty were younger 
than 64 years.
Table 3 shows prevalence differences and prevalence 
ratios with 95% CI for each definition of multimorbidity 
with frailty between occupational groups for women and 
men at the ages 30, 55 and 80 years.
Prevalence differences in percentage points (pp) for 
two- condition multimorbidity with one dimension of 
frailty between high and low occupational groups were 
largest in women at 30 years, 17 (14 to 20) pp and 55 
years, 15 (13 to 17) pp, and for men at 55 years, 15 (13 to 
17) pp and 80 years, 14 (9 to 18) pp. The prevalence ratio 
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Table 3 Prevalence ratios (PR) and prevalence differences (PD) with 95% CI between occupational groups and multimorbidity 
with frailty, stratified by sex
Age,
years
Occupational
group
Women Men
Two conditions of multimorbidity and one dimension of frailty
PR (95% CI) PD (95% CI) PR (95% CI) PD (95% CI)
30 High 1.00 (Ref.) 0.00 (Ref.) 1.00 (Ref.) 0.00 (Ref.)
Middle 1.36 (1.11 to 1.65) 0.06 (0.02 to 0.09) 0.93 (0.70 to 1.23) −0.01 (−0.06 to 0.03)
Low 2.09 (1.76 to 2.47) 0.17 (0.14 to 0.20) 1.32 (1.04 to 1.67) 0.05 (0.01 to 0.09)
55 High 1.00 (Ref.) 0.00 (Ref.) 1.00 (Ref.) 0.00 (Ref.)
Middle 1.22 (1.13 to 1.31) 0.07 (0.04 to 0.09) 1.34 (1.23 to 1.45) 0.08 (0.06 to 0.11)
Low 1.48 (1.38 to 1.58) 0.15 (0.13 to 0.17) 1.60 (1.48 to 1.72) 0.15 (0.13 to 0.17)
80 High 1.00 (Ref.) 0.00 (Ref.) 1.00 (Ref.) 0.00 (Ref.)
Middle 0.96 (0.86 to 1.08) −0.02 (−0.09 to 0.05) 1.23 (1.12 to 1.35) 0.12 (0.06 to 0.17)
Low 1.05 (0.95 to 1.16) 0.03 (−0.03 to 0.09) 1.27 (1.15 to 1.39) 0.14 (0.09 to 0.18)
Age,
years
Occupational
group
Three conditions of multimorbidity and two dimensions of frailty
PR (95% CI) PD (95% CI) PR (95% CI) PD (95% CI)
30 High 1.00 (Ref.) 0.00 (Ref.) 1.00 (Ref.) 0.00 (Ref.)
Middle 2.31 (1.56 to 3.40) 0.04 (0.02 to 0.06) 1.29 (0.77 to 2.17) 0.01 (−0.01 to 0.03)
Low 3.59 (2.53 to 5.08) 0.08 (0.06 to 0.10) 1.60 (1.02 to 2.51) 0.02 (0.00 to 0.04)
55 High 1.00 0.00 1.00 0.00
Middle 1.31 (1.14 to 1.50) 0.04 (0.02 to 0.06) 1.62 (1.40 to 1.87) 0.06 (0.04 to 0.07)
Low 1.78 (1.59 to 2.00) 0.10 (0.08 to 0.11) 2.05 (1.80 to 2.33) 0.09 (0.08 to 0.11)
80 High 1.00 (Ref.) 0.00 (Ref.) 1.00 (Ref.) 0.00 (Ref.)
Middle 1.17 (0.94 to 1.47) 0.05 (−0.02 to 0.11) 1.26 (1.06 to 1.50) 0.07 (0.02 to 0.11)
Low 1.16 (0.94 to 1.42) 0.04 (−0.01 to 0.10) 1.22 (1.04 to 1.44) 0.06 (0.01 to 0.10)
for the low occupational group compared with the high 
occupational group, for two- condition multimorbidity 
with one dimension of frailty, was greatest in women at 
30 years, 2.09 (1.76 to 2.47) and in men at 55 years, 1.60 
(1.48 to 1.72). The prevalence ratio decreased in both 
sexes in high age and was at 80 years 1.05 (0.95 to 1.16) 
for women and 1.27 (1.15 to 1.39) for men.
Correspondingly, prevalence differences between high 
and low occupational groups for three- condition multi-
morbidity with two dimensions of frailty were largest in 
women at 30 years, 8 (6 to 10) pp and 55 years, 10 (8 
to 11) pp and in men at 55 years, 9 (8 to 11) pp and 80 
years, 6 (1 to 10) pp. Prevalence ratio, comparing the low 
occupational group with the highest occupational group 
for three- conditions multimorbidity with two conditions 
of frailty, was greatest in women at 30 years, 3.59 (1.43 
to 5.08) and in men at 55 years, 2.05 (1.80 to 2.33). The 
prevalence ratio decreased in both sexes in high age and 
was at 80 years 1.16 (0.94 to 1.42) for women and 1.22 
(1.04 to 1.44) for men.
DIsCussIOn
Main results
In this adult population health study, multimorbidity 
with frailty was common as 39% met the criteria of 
two- condition multimorbidity plus one dimension of 
frailty and 17% met the criteria of three- condition multi-
morbidity plus two dimensions of frailty. Proportions 
increased with lower occupational group, higher age and 
female sex from 25 to 74 years, but was common across 
age groups in both sexes. Occupational inequalities were 
consistent in both sexes until high age, diminishing in 
women, while still present in men at age 80 years.
Comparison with existing literature
Investigating two measures of multimorbidity with frailty 
in one sample offers a unique direct comparison of 
occurrences and socioeconomic gradients. Lower overall 
prevalence for the stricter measure three- condition 
multimorbidity with two dimensions of frailty is expected. 
Defining multimorbidity by three or more conditions 
differentiates into older age.26 29 The joint measure multi-
morbidity and frailty show the same tendency, as 62% of 
75–100 year olds met the criteria of at least two- condition 
multimorbidity with one dimension of frailty, while 32% 
reported three- condition multimorbidity with two dimen-
sions of frailty. In line with individual studies on multi-
morbidity4 24 and frailty,25 most individuals with co- present 
multimorbidity and frailty are younger than 64 years.
A recent commentary1 emphasised exploring multimor-
bidity guidelines and frailty as part of multimorbidity’s 
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complexity, and overlap of multimorbidity and frailty 
has newly been reviewed.28 A pooled prevalence of 
16% (95% CI 12% to 21%) was reported for two condi-
tions multimorbidity with the frailty phenotype among 
elderly,28 while 39% in our study reported at least two 
conditions of multimorbidity with one dimension of 
frailty. The prevalence differences are likely explained 
by differences in methods. The articles included in the 
review studied age 60 years and older. Still, the preva-
lence of multimorbidity is low. All but one defined 
multimorbidity from lists of less than 12 conditions and 
prevalences are probably underestimated.26 29 Frailty too 
was only operationalised with the biophysical model, 
while more people are expected to be detected using a 
multidimensional measure.
We have not identified studies on prevalence and social 
determinants of multimorbidity with frailty. Low social 
position,18 19 older age18 20 and female sex18 20 are known 
common determinants of multimorbidity and frailty. We 
therefore argue that the direction of the sociodemo-
graphic determinants in this study is as expected. The 
magnitudes of these gradients, however, have not been 
comparable with other studies.
Mechanisms to explain findings
The aggregation of ill health, multimorbidity and frailty 
included in lower socioeconomic positions is explained 
by numerous theories. Overall, unequal distribution 
of power, income and resources result in fundamental 
different conditions of daily life yielding inequalities in 
health.17 With regard to occupation, several mechanisms 
can explain associations to health outcomes. The higher 
occupational group is expected to have higher, more 
stable income,35 39 more beneficial social networks39 
and more autonomy and control35 39 at work. Adverse 
working conditions such as exposure to toxic work envi-
ronments21 or demanding physical requirements39 tend 
to cluster in lower occupational groups.17 Persisting 
health inequalities in assumed egalitarian Nordic coun-
tries is partly understood as mortality selection, where, 
given the well- developed healthcare and welfare systems, 
frail individuals survive, but likely end up in a low social 
position.16 Further, smoking, overall morbidity and 
mortality decrease at a higher rate among higher than 
lower social groups.16 In this study, the demographic age 
distribution explain the high number of 45 to 64 years 
old with co- present multimorbidity and frailty. Addi-
tionally, incidence of new conditions is associated with 
count of conditions at baseline,4 as well as age,4 thus 
individuals in lower occupational groups may aggregate 
conditions faster. The bidirectional association of health 
and occupation may explain higher occupational group 
prevalence ratios in younger individuals,21 while lower 
ratios by increasing age are expected, since multimor-
bidity with frailty is more common40 with advancing age. 
Finally, survival bias justifies diminishing occupational 
differences at age 80 years.
strengths and limitations
Materials and methods meet the standards of studies 
on multimorbidity, frailty and social health inequali-
ties, strengthening this study. In multimorbidity studies, 
population- based health surveys are the most frequent 
study design,41 and prevalence estimates from self- reports 
are justified when studying large samples.26 Deriving 
the condition count multimorbidity measures from a 
complete list of single- entity conditions is shown to yield 
proper prevalence estimates.29 A multidimensional frailty 
measure agrees with a holistic, unrestricted on age, 
conceptual definition of frailty14 and with common frailty 
scales, which share ability to show associations to age, 
sex and mortality.20 In descriptive studies, any measure 
of socioeconomic position will reveal health inequalities, 
if such exists.21 Occupation is an established marker for 
socioeconomic position,21 in which this study had indi-
vidual data classified to facilitate international compar-
ison. Finally, socioeconomic differences are explored as 
both absolute and relative measures16 and presented by 
sex.18
There are always limitations in secondary analysis of 
data collected a priori and not for the purpose of the 
current study. Measures of multimorbidity and frailty 
are also manifold, and operationalisations were adjusted 
to fit the available data. This challenges the external 
validity, and comparability between studies, however, is 
sought reduced through transparency of morbidities 
included and construction of variables. A majority of 
included multimorbidity conditions do not contain infor-
mation regarding duration. Thus, reported prevalence 
of multimorbidity may be overestimated and not repre-
sent true chronicity. It is recognised that frailty scales 
may differ in accuracy of detecting frailty in younger age 
groups10 20; however, frailty symptoms are of great clinical 
value regardless of age.10 42 The accuracy of the frailty vari-
ables were not explored and frailty was measured solely as 
self- report, an approach that may underestimate overall 
prevalence43 and overestimate proportion among women 
compared with men.43
Lastly, in the HUNT3 Survey, participants were asked 
for their ‘main’ occupation, which is not necessarily the 
current or longest lasting occupation, more commonly 
studied.39 Younger than middle aged may to some extent 
be misclassified in the lower occupational group, which 
will underestimate social differences in health among 
younger subjects. Occupational data may obscure current 
social context39 and underestimate socioeconomic 
inequalities. Thus, the study would have benefitted from 
exploring socioeconomic position with several indica-
tors,44 such as individual education and income or a 
household measure.
Attendance in the HUNT3 Survey varied by age, sex 
and social position32; still, the HUNT Study is consid-
ered representative for Norway as a whole45 and the 
cohort follows trends in health development in western 
high- income countries.46–48 Depression hindered partic-
ipation,32 which may yield underestimation of both 
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multimorbidity and frailty. An overall bias towards healthy 
elders is probable, since eligibility depended on atten-
dance at a screening station.
Implications for clinical practice and policy makers
This study aimed to quantify the total prevalence of adults 
in the general population who might need complex, 
multidisciplinary care assessed as the joint measure 
multimorbidity with frailty. In a clinical context, the defi-
nition of at least three- condition multimorbidity with 
two dimensions of frailty to detect individuals for whom 
to initiate a multimorbid approach to care seems more 
feasible. Despite acknowledgement of the association of 
multimorbidity and frailty with age, sex and socioeco-
nomic position, guidelines and interventions have yet to 
take this into account in assessment and management 
for multimorbidity.49 Based on literature and repro-
duction of social gradients in our study, we suggest that 
clinicians consider evaluation of multimorbidity and 
frailty in younger age groups with social context in mind. 
Further research on implementation of the multimorbid 
approach to care model and mortality is needed before 
recommending changing inclusion criteria in a guideline. 
Since multimorbidity is becoming the norm, the organi-
sation of healthcare should reform to fit person- centred, 
coordinated, multidisciplinary care.6 10 50 To prevent cases 
of multimorbidity and frailty and minimise social discrep-
ancies, both universal and targeted life cycle approaches 
seem necessary.51
Frailty is independently associated with mortality, 
adjusted for multimorbidity,25 and is reversible.52 Thus, 
detection of frailty is relevant for both public health and 
clinical purposes.
Future research
Some forms of biases are possible for both multimor-
bidity, frailty and social position, and a careful interpre-
tation of findings is warranted. However, multimorbidity 
with frailty is common in this general population and 
with occupational inequalities throughout adulthood, 
even with stricter definitions. This adds knowledge to 
the public health literature about the sociodemographic 
distribution of multimorbidity with frailty in younger 
age groups, as well as very old individuals. On this back-
ground, we recommend exploring the sociodemographic 
distribution of alternative measures on multimorbidity, 
including patterns, aiming to detect individuals suspected 
in high need of complex, multidisciplinary healthcare. 
Furthermore, such measurements can be compared as 
prognostic factors for healthcare utilisation and mortality.
COnClusIOn
Multimorbidity with frailty is common from young adult-
hood onward, with consistent socioeconomic inequalities 
until 80 years old. Prevention will require a proportionate 
universal approach on social determinants of health 
throughout the entire life span. The crucial need for 
person- centred multimorbid approach to care that 
acknowledges social context, demands reforms in health-
care organisational structure, medical education and 
treatment. Further research on competing measures of 
high- need multimorbidity and the association of these 
factors with healthcare utilisation and mortality should be 
explored by socioeconomic position, age and sex.
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